Search:

Management Team

Jack Ball — Chief Executive Officer

Mr. Ball brings a solid track record of life sciences leadership with a strong background in commercial operations and extensive experience in the life science markets. Most recently, he served as Chief Commercial Officer of Accuri Cytometers, Inc., before its acquisition by BD Biosciences in 2011. Prior to joining Accuri, Mr. Ball was CEO of Amnis Corporation, a venture-backed technology start-up developing high-end imaging flow cytometers. He also served as Chief Commercial Officer for Molecular Probes, Inc. (now a part of Life Technologies), the world leader in reagents for molecular biology and cell analysis. Prior to joining Molecular Probes, Mr. Ball was the Senior VP & General Manager of the Life Sciences Group at Orchid Biosciences, and a senior executive at Amersham Pharmacia Biotech Inc., where he rose to President, North America, and was responsible for sales, marketing, and customer support.

In addition to Solulink, Mr. Ball serves on the board of directors of 3D Biomatrix, IntelliCyt, RealBio Technology, Swift Bioscience and ViroCyt, as well as the non-profit organization, the Association of Commercial Professionals - Life Sciences (ACP-LS).

Solulink's Latest Headlines

6/2015 - Solulink and TriLink BioTechnologies Enter into Manufacturing and Distribution Agreement

1/24/14 - An article discussing Solulink’s new revolutionary dye mix and match antibody labeling technology, HybriLink™ was published in the January 24, 2014, ChemBioChem Journal. The article is the result of a collaboration between the University of Chicago and Solulink:
DNA-Directed Assembly of Antibody–Fluorophore Conjugates for Quantitative Multiparametric Flow Cytometry

Solulink Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer